Covid-19 roundup: Temasek leads a $250M raise for BioN­Tech as first Covid-19 mR­NA vac­cine da­ta looms; Chi­na's mil­i­tary OKs first use of coro­n­avirus vac­cine

Sin­ga­pore’s gi­ant fund run by Temasek is putting some fi­nan­cial mus­cle be­hind BioN­Tech $BN­TX as the Pfiz­er part­ner pre­pares to post the first cut of its da­ta on their mR­NA vac­cine to com­bat Covid-19.

Temasek is lead­ing a $250 mil­lion in­jec­tion in­to the Ger­man biotech, one of a small pack of mR­NA play­ers at­tempt­ing to field a vac­cine to fight the glob­al pan­dem­ic that’s been rat­tling the world. Mod­er­na is in front of the mR­NA pack with Phase III plans.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER